nDatalyze Corp.

C$0.07As of Sun 8 Nov 2026, 12:00 UTC
CSE:NDATHealthcare
Country Canada
PE (Fwd) •••
TSR 7Y CAGR 2.22%
Div yield —
ROE (67.70%)
Health Information Services
Beta (5Y) (0.01)
PE TTM —
TSR TTM —
Mkt cap C$2.893M
ROIC (32.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0678
(3.09%)
(60.56%)
Hold 10|8|7|9|12
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
12.14%
13.07%
11.99%
15.46%
Revenue$M
0.357
0.356
0.374
0.384
6.82%
8.72%
8.82%
11.04%
Peers (US$2.048M)
Cap (US$)
PE
2.148M
—
Capital
TTM
5Y
10Y
Leveragex
1.557
0.030
0.029
EBIT/Intx
1.791
0.331
0.313
Own earn%
302.80
101.94
88.64
Sh yield%
37.93
10.41
9.59
Owners
Insiders/Inst%
14.05
74.85
Short interest%
2.41
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–13
$1 testx
0.0
Incr. ROIC%
9